Forefront Analytics LLC grew its holdings in shares of Athira Pharma, Inc. (NASDAQ:ATHA – Free Report) by 43.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 29,765 shares of the company’s stock after purchasing an additional 8,955 shares during the […]
Immatics (NASDAQ:IMTX – Get Free Report)’s stock price hit a new 52-week high during trading on Wednesday . The stock traded as high as $13.53 and last traded at $13.41, with a volume of 499593 shares changing hands. The stock had previously closed at $12.42. Analyst Upgrades and Downgrades Separately, Mizuho boosted their target price […]
Athira Pharma, Inc. (NASDAQ:ATHA – Get Free Report) was the target of a significant decrease in short interest in the month of May. As of May 15th, there was short interest totalling 923,300 shares, a decrease of 12.1% from the April 30th total of 1,050,000 shares. Based on an average daily volume of 309,500 shares, […]
Shares of Neumora Therapeutics, Inc. (NASDAQ:NMRA – Get Free Report) have been given an average recommendation of “Moderate Buy” by the seven brokerages that are covering the stock, Marketbeat.com reports. One equities research analyst has rated the stock with a hold recommendation and six have given a buy recommendation to the company. The average twelve-month […]
Replimune Group, Inc. (NASDAQ:REPL – Get Free Report) CEO Sushil Patel sold 20,194 shares of the business’s stock in a transaction that occurred on Thursday, May 16th. The shares were sold at an average price of $6.47, for a total value of $130,655.18. Following the completion of the sale, the chief executive officer now owns […]